1. BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.
- Author
-
Maël, Heiblig, Arnaud, Pigneux, Audrey, Bidet, Evelyne, Callet-Bauchu, Kaddour, Chabane, Pierre-Yves, Dumas, Gilles, Salles, and Maël, Heiblig
- Subjects
- *
ABL1 gene , *DRUG therapy , *PROTEIN-tyrosine kinase inhibitors , *CHRONIC myeloid leukemia , *DISEASE susceptibility , *ACUTE myeloid leukemia diagnosis , *ANTINEOPLASTIC agents , *HETEROCYCLIC compounds , *IMIDAZOLES , *TREATMENT effectiveness , *DIAGNOSIS , *THERAPEUTICS - Abstract
The article discusses the case study of a 71-year-old white woman diagnosed with BCR-ABL-positive acute myeloid leukemia (AML) and mentions the use of ponatinib drug as a treatment strategy. Topics discussed include the difference in diagnosis between BCR-ABL+ de novo AML and chronic myeloid leukemia, the physiological response to tyrosine kinase inhibitors and the patient death from digestive diathesis.
- Published
- 2017
- Full Text
- View/download PDF